CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Egile nagusia: | Ullah, Mohammad |
---|---|
Beste egile batzuk: | Islam, Farzana |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2023
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/19355 |
Antzeko izenburuak
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
nork: Maria, Amatul
Argitaratua: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
nork: Shaikat, Mahdi Mubin
Argitaratua: (2023) -
A review on CRISPR-Cas system based applications in Oncology
nork: Sadia, Mir
Argitaratua: (2022) -
A review on CRISPR Technology as an Antiviral Tool
nork: Srishti, Sanjida Ahmed
Argitaratua: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
nork: Eva, Israt Ara Jannat
Argitaratua: (2023)